Julie Miller, MD, PhD
Julie Miller, MD, PhD
Neuro-Oncologist
Assistant Professor, Harvard Medical School
About Julie Miller, MD, PhD
Clinical Interests:
- Brain and spinal cord tumors
- Brain Metastases
- Brain tumors
- Glioblastoma
- low-grade gliomas
- Meningiomas
- Neuro-oncology
Treats:
- Adult
Locations
Mass General Cancer Center: Neuro-Oncology
55 Fruit St.
Yawkey Center for Outpatient Care
Boston, MA 02114
Phone: 617-724-8770
Phone: 877-518-2619
Medical Education
- M.D.; Ph.D., Stanford University School of Medicine
- Residency, Brigham and Women's Hospital
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Neuro-Oncology, United Council for Neurologic Subspecialties
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicare
- Medicare ACO
- Multiplan
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Miller is interested in understanding the genetic and molecular mechanisms driving the development and progression of primary brain tumors, particularly IDH-mutant gliomas and glioblastoma. Her recent research has focused on the disruption of normal metabolism that is observed in IDH-mutant gliomas, with the goal of developing new drugs and treatment strategies to more effectively treat patients with these tumors. She has also been exploring the molecular changes that occur in IDH-mutant gliomas following chemotherapy exposure to better understand mechanisms of resistance and develop ways to prolong the clinical benefit of chemotherapy.
Publications
-
Selected Recent Publications:
Miller JJ, Cahill DP. MGMT promoter methylation and hypermutant recurrence in IDH mutant lower-grade glioma. Neuro Oncol. 2020 Nov 26.
Nagashima H, Lee CK, Tateishi K, Higuchi F, Subramanian M, Rafferty S, Melamed L, Miller JJ, Wakimoto H, Cahill DP. Poly(ADP-ribose) Glycohydrolase Inhibition Sequesters NAD+ to Potentiate the Metabolic Lethality of Alkylating Chemotherapy in IDH-Mutant Tumor Cells. Cancer Discov. 2020 Nov.
Miller JJ, Fink A, Banagis JA, Nagashima H, Subramanian M, Lee CK, Melamed L, Tummala SS, Tateishi K, Wakimoto H, Cahill DP. Sirtuin activation targets IDH-mutant tumors. Neuro Oncol. 2020 Jul 26.
Miller JJ, Loebel F, Juratli TA, Tummala SS, Williams EA, Batchelor TT, Arrillaga-Romany I, Cahill DP. Accelerated progression of IDH mutant glioma after first recurrence. Neuro Oncol. 2019 May 6.
Reviews: Comments and Ratings
Patient Gateway
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
A Top Hospital in America
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.
MHB almost always fails to forward my images CD to my provider via US mail. Also the system for imaging providers to electronically send these records to you is complicated and an epic failure.
Dr. Julie Miller is an excellent, skilled, and incredibly compassionate care provider. I feel very fortunate to be under her care.
5 Star Visit
She listens, explains and takes the time to answer questions
I need a little bit more time to recuperate so that way I can professionally put a reference about the whole situation, the treatment, the doctors, the nurses. I will definitely write back to you guys. Thank you.
Dr. Miller combined her medical expertise with warmth and humor.
Incredibly compassionate and well coordinated care. I look forward to working with this provider
The doctor was very informative about the situation
The experience was excellent!
Dr. Miller is very thorough. She helped me understand my MRI completely. I am very comfortable with her.